Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies

Completed · Phase 1

Conditions studied: Advanced Solid Malignancies

In brief

Participants will take GW572016 by mouth daily each cycle (cycles 28 days in length) and will be given Topotecan intravenously on Days 1, 8 and 15.

Key facts

Study ID

NCT00295243

Run by

Mayo Clinic

People needed

25

Starts

2004-09-01

Expected to finish

2006-11-01

Last updated by the study team

2011-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.